Global Diabetes Treatment Device Market Research Report 2021
1 Diabetes Treatment Device Market Overview
- 1.1 Product Overview and Scope of Diabetes Treatment Device
- 1.2 Diabetes Treatment Device Segment by Type
- 1.2.1 Global Diabetes Treatment Device Sales Growth Rate Comparison by Type (2021-2027)
- 1.2.2 Insulin Pens
- 1.2.3 Insulin Pumps
- 1.2.4 Insulin Jet Injectors
- 1.2.5 Insulin Syringes
- 1.2.6 Others
- 1.3 Diabetes Treatment Device Segment by Application
- 1.3.1 Diabetes Treatment Device Sales Comparison by Application: (2021-2027)
- 1.3.2 Hospitals
- 1.3.3 Clinics
- 1.3.4 Homecare
- 1.4 Global Diabetes Treatment Device Market Size Estimates and Forecasts
- 1.4.1 Global Diabetes Treatment Device Revenue 2016-2027
- 1.4.2 Global Diabetes Treatment Device Sales 2016-2027
- 1.4.3 Diabetes Treatment Device Market Size by Region: 2016 Versus 2021 Versus 2027
2 Diabetes Treatment Device Market Competition by Manufacturers
- 2.1 Global Diabetes Treatment Device Sales Market Share by Manufacturers (2016-2021)
- 2.2 Global Diabetes Treatment Device Revenue Market Share by Manufacturers (2016-2021)
- 2.3 Global Diabetes Treatment Device Average Price by Manufacturers (2016-2021)
- 2.4 Manufacturers Diabetes Treatment Device Manufacturing Sites, Area Served, Product Type
- 2.5 Diabetes Treatment Device Market Competitive Situation and Trends
- 2.5.1 Diabetes Treatment Device Market Concentration Rate
- 2.5.2 The Global Top 5 and Top 10 Largest Diabetes Treatment Device Players Market Share by Revenue
- 2.5.3 Global Diabetes Treatment Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diabetes Treatment Device Retrospective Market Scenario by Region
- 3.1 Global Diabetes Treatment Device Retrospective Market Scenario in Revenue by Region: 2016-2021
- 3.2 Global Diabetes Treatment Device Retrospective Market Scenario in Sales by Region: 2016-2021
- 3.3 North America Diabetes Treatment Device Market Facts & Figures by Country
- 3.3.1 North America Diabetes Treatment Device Sales by Country
- 3.3.2 North America Diabetes Treatment Device Revenue by Country
- 3.3.3 U.S.
- 3.3.4 Canada
- 3.4 Europe Diabetes Treatment Device Market Facts & Figures by Country
- 3.4.1 Europe Diabetes Treatment Device Sales by Country
- 3.4.2 Europe Diabetes Treatment Device Revenue by Country
- 3.4.3 Germany
- 3.4.4 France
- 3.4.5 U.K.
- 3.4.6 Italy
- 3.4.7 Russia
- 3.5 Asia Pacific Diabetes Treatment Device Market Facts & Figures by Region
- 3.5.1 Asia Pacific Diabetes Treatment Device Sales by Region
- 3.5.2 Asia Pacific Diabetes Treatment Device Revenue by Region
- 3.5.3 China
- 3.5.4 Japan
- 3.5.5 South Korea
- 3.5.6 India
- 3.5.7 Australia
- 3.5.8 Taiwan
- 3.5.9 Indonesia
- 3.5.10 Thailand
- 3.5.11 Malaysia
- 3.5.12 Philippines
- 3.5.13 Vietnam
- 3.6 Latin America Diabetes Treatment Device Market Facts & Figures by Country
- 3.6.1 Latin America Diabetes Treatment Device Sales by Country
- 3.6.2 Latin America Diabetes Treatment Device Revenue by Country
- 3.6.3 Mexico
- 3.6.4 Brazil
- 3.6.5 Argentina
- 3.7 Middle East and Africa Diabetes Treatment Device Market Facts & Figures by Country
- 3.7.1 Middle East and Africa Diabetes Treatment Device Sales by Country
- 3.7.2 Middle East and Africa Diabetes Treatment Device Revenue by Country
- 3.7.3 Turkey
- 3.7.4 Saudi Arabia
- 3.7.5 UAE
4 Global Diabetes Treatment Device Historic Market Analysis by Type
- 4.1 Global Diabetes Treatment Device Sales Market Share by Type (2016-2021)
- 4.2 Global Diabetes Treatment Device Revenue Market Share by Type (2016-2021)
- 4.3 Global Diabetes Treatment Device Price by Type (2016-2021)
5 Global Diabetes Treatment Device Historic Market Analysis by Application
- 5.1 Global Diabetes Treatment Device Sales Market Share by Application (2016-2021)
- 5.2 Global Diabetes Treatment Device Revenue Market Share by Application (2016-2021)
- 5.3 Global Diabetes Treatment Device Price by Application (2016-2021)
6 Key Companies Profiled
- 6.1 Roche
- 6.1.1 Roche Corporation Information
- 6.1.2 Roche Description and Business Overview
- 6.1.3 Roche Diabetes Treatment Device Sales, Revenue and Gross Margin (2016-2021)
- 6.1.4 Roche Product Portfolio
- 6.1.5 Roche Recent Developments/Updates
- 6.2 Tandem Diabetes Care, Inc.
- 6.2.1 Tandem Diabetes Care, Inc. Corporation Information
- 6.2.2 Tandem Diabetes Care, Inc. Description and Business Overview
- 6.2.3 Tandem Diabetes Care, Inc. Diabetes Treatment Device Sales, Revenue and Gross Margin (2016-2021)
- 6.2.4 Tandem Diabetes Care, Inc. Product Portfolio
- 6.2.5 Tandem Diabetes Care, Inc. Recent Developments/Updates
- 6.3 B. Braun Melsungen AG
- 6.3.1 B. Braun Melsungen AG Corporation Information
- 6.3.2 B. Braun Melsungen AG Description and Business Overview
- 6.3.3 B. Braun Melsungen AG Diabetes Treatment Device Sales, Revenue and Gross Margin (2016-2021)
- 6.3.4 B. Braun Melsungen AG Product Portfolio
- 6.3.5 B. Braun Melsungen AG Recent Developments/Updates
- 6.4 Medtronic
- 6.4.1 Medtronic Corporation Information
- 6.4.2 Medtronic Description and Business Overview
- 6.4.3 Medtronic Diabetes Treatment Device Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Medtronic Product Portfolio
- 6.4.5 Medtronic Recent Developments/Updates
- 6.5 BD
- 6.5.1 BD Corporation Information
- 6.5.2 BD Description and Business Overview
- 6.5.3 BD Diabetes Treatment Device Sales, Revenue and Gross Margin (2016-2021)
- 6.5.4 BD Product Portfolio
- 6.5.5 BD Recent Developments/Updates
- 6.6 Novo Nordisk A/S
- 6.6.1 Novo Nordisk A/S Corporation Information
- 6.6.2 Novo Nordisk A/S Description and Business Overview
- 6.6.3 Novo Nordisk A/S Diabetes Treatment Device Sales, Revenue and Gross Margin (2016-2021)
- 6.6.4 Novo Nordisk A/S Product Portfolio
- 6.6.5 Novo Nordisk A/S Recent Developments/Updates
- 6.7 Abbott
- 6.6.1 Abbott Corporation Information
- 6.6.2 Abbott Description and Business Overview
- 6.6.3 Abbott Diabetes Treatment Device Sales, Revenue and Gross Margin (2016-2021)
- 6.4.4 Abbott Product Portfolio
- 6.7.5 Abbott Recent Developments/Updates
- 6.8 Sanofi
- 6.8.1 Sanofi Corporation Information
- 6.8.2 Sanofi Description and Business Overview
- 6.8.3 Sanofi Diabetes Treatment Device Sales, Revenue and Gross Margin (2016-2021)
- 6.8.4 Sanofi Product Portfolio
- 6.8.5 Sanofi Recent Developments/Updates
7 Diabetes Treatment Device Manufacturing Cost Analysis
- 7.1 Diabetes Treatment Device Key Raw Materials Analysis
- 7.1.1 Key Raw Materials
- 7.1.2 Key Suppliers of Raw Materials
- 7.2 Proportion of Manufacturing Cost Structure
- 7.3 Manufacturing Process Analysis of Diabetes Treatment Device
- 7.4 Diabetes Treatment Device Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
- 8.1 Marketing Channel
- 8.2 Diabetes Treatment Device Distributors List
- 8.3 Diabetes Treatment Device Customers
9 Diabetes Treatment Device Market Dynamics
- 9.1 Diabetes Treatment Device Industry Trends
- 9.2 Diabetes Treatment Device Growth Drivers
- 9.3 Diabetes Treatment Device Market Challenges
- 9.4 Diabetes Treatment Device Market Restraints
10 Global Market Forecast
- 10.1 Diabetes Treatment Device Market Estimates and Projections by Type
- 10.1.1 Global Forecasted Sales of Diabetes Treatment Device by Type (2022-2027)
- 10.1.2 Global Forecasted Revenue of Diabetes Treatment Device by Type (2022-2027)
- 10.2 Diabetes Treatment Device Market Estimates and Projections by Application
- 10.2.1 Global Forecasted Sales of Diabetes Treatment Device by Application (2022-2027)
- 10.2.2 Global Forecasted Revenue of Diabetes Treatment Device by Application (2022-2027)
- 10.3 Diabetes Treatment Device Market Estimates and Projections by Region
- 10.3.1 Global Forecasted Sales of Diabetes Treatment Device by Region (2022-2027)
- 10.3.2 Global Forecasted Revenue of Diabetes Treatment Device by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
- 12.1 Methodology/Research Approach
- 12.1.1 Research Programs/Design
- 12.1.2 Market Size Estimation
- 12.1.3 Market Breakdown and Data Triangulation
- 12.2 Data Source
- 12.2.1 Secondary Sources
- 12.2.2 Primary Sources
- 12.3 Author List
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Insulin Pens
Insulin Pumps
Insulin Jet Injectors
Insulin Syringes
Others
Segment by Application
Hospitals
Clinics
Homecare
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Roche
Tandem Diabetes Care, Inc.
B. Braun Melsungen AG
Medtronic
BD
Novo Nordisk A/S
Abbott
Sanofi